SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-270377
Filing Date
2023-11-03
Accepted
2023-11-03 16:11:17
Documents
55
Period of Report
2023-11-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d556062d8k.htm   iXBRL 8-K 29047
2 EX-99.1 d556062dex991.htm EX-99.1 19199
3 EX-99.2 d556062dex992.htm EX-99.2 41965
8 GRAPHIC g556062ex99_2s10g1.jpg GRAPHIC 126027
9 GRAPHIC g556062ex99_2s11g1.jpg GRAPHIC 155582
10 GRAPHIC g556062ex99_2s12g1.jpg GRAPHIC 100940
11 GRAPHIC g556062ex99_2s13g1.jpg GRAPHIC 95991
12 GRAPHIC g556062ex99_2s14g1.jpg GRAPHIC 84757
13 GRAPHIC g556062ex99_2s15g1.jpg GRAPHIC 99194
14 GRAPHIC g556062ex99_2s16g1.jpg GRAPHIC 95804
15 GRAPHIC g556062ex99_2s17g1.jpg GRAPHIC 107171
16 GRAPHIC g556062ex99_2s18g1.jpg GRAPHIC 97247
17 GRAPHIC g556062ex99_2s19g1.jpg GRAPHIC 85826
18 GRAPHIC g556062ex99_2s1g1.jpg GRAPHIC 98317
19 GRAPHIC g556062ex99_2s20g1.jpg GRAPHIC 133095
20 GRAPHIC g556062ex99_2s21g1.jpg GRAPHIC 103499
21 GRAPHIC g556062ex99_2s22g1.jpg GRAPHIC 88149
22 GRAPHIC g556062ex99_2s23g1.jpg GRAPHIC 96240
23 GRAPHIC g556062ex99_2s24g1.jpg GRAPHIC 85598
24 GRAPHIC g556062ex99_2s25g1.jpg GRAPHIC 86189
25 GRAPHIC g556062ex99_2s26g1.jpg GRAPHIC 103781
26 GRAPHIC g556062ex99_2s27g1.jpg GRAPHIC 122756
27 GRAPHIC g556062ex99_2s28g1.jpg GRAPHIC 98786
28 GRAPHIC g556062ex99_2s29g1.jpg GRAPHIC 29041
29 GRAPHIC g556062ex99_2s2g1.jpg GRAPHIC 200636
30 GRAPHIC g556062ex99_2s30g1.jpg GRAPHIC 101181
31 GRAPHIC g556062ex99_2s31g1.jpg GRAPHIC 80220
32 GRAPHIC g556062ex99_2s32g1.jpg GRAPHIC 143659
33 GRAPHIC g556062ex99_2s33g1.jpg GRAPHIC 116243
34 GRAPHIC g556062ex99_2s34g1.jpg GRAPHIC 79963
35 GRAPHIC g556062ex99_2s35g1.jpg GRAPHIC 104539
36 GRAPHIC g556062ex99_2s36g1.jpg GRAPHIC 127364
37 GRAPHIC g556062ex99_2s37g1.jpg GRAPHIC 116037
38 GRAPHIC g556062ex99_2s38g1.jpg GRAPHIC 90457
39 GRAPHIC g556062ex99_2s39g1.jpg GRAPHIC 130662
40 GRAPHIC g556062ex99_2s3g1.jpg GRAPHIC 122979
41 GRAPHIC g556062ex99_2s40g1.jpg GRAPHIC 113134
42 GRAPHIC g556062ex99_2s4g1.jpg GRAPHIC 111810
43 GRAPHIC g556062ex99_2s5g1.jpg GRAPHIC 97341
44 GRAPHIC g556062ex99_2s6g1.jpg GRAPHIC 99199
45 GRAPHIC g556062ex99_2s7g1.jpg GRAPHIC 83630
46 GRAPHIC g556062ex99_2s8g1.jpg GRAPHIC 114160
47 GRAPHIC g556062ex99_2s9g1.jpg GRAPHIC 111523
  Complete submission text file 0001193125-23-270377.txt   6116800

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA snse-20231103.xsd EX-101.SCH 3871
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snse-20231103_def.xml EX-101.DEF 14096
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE snse-20231103_lab.xml EX-101.LAB 23425
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snse-20231103_pre.xml EX-101.PRE 15129
49 EXTRACTED XBRL INSTANCE DOCUMENT d556062d8k_htm.xml XML 5216
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39980 | Film No.: 231376439
SIC: 2834 Pharmaceutical Preparations